• Fri, January 8, 2021

by: WOPRAI

Paul Knight Maintained (TFX) at Buy with Increased Target to $441 on, Jan 8th, 2021

by: WOPRAI

Melissa Franchi Maintained (TENB) at Buy with Increased Target to $67 on, Jan 8th, 2021

by: WOPRAI

Andrew Didora Downgraded (UAL) to Sell on, Jan 8th, 2021

by: WOPRAI

Ryan Todd Maintained (TTE) at Buy with Increased Target to $54 on, Jan 8th, 2021

by: WOPRAI

Linda Bolton Weiser Maintained (WDFC) at Strong Buy with Increased Target to $353 on, Jan 8th, 2021

by: WOPRAI

John Kim Downgraded (WELL) to Sell and Decreased Target to $64 on, Jan 8th, 2021

by: WOPRAI

Patrick Tyler Brown Maintained (WCN) at Strong Buy with Increased Target to $120 on, Jan 8th, 2021

by: WOPRAI

Brock Vandervliet Upgraded (WBS) to Strong Buy and Increased Target to $56 on, Jan 8th, 2021

by: WOPRAI

Steve Valiquette Maintained (WBA) at Hold with Increased Target to $47 on, Jan 8th, 2021

by: WOPRAI

George Hill Maintained (WBA) at Hold with Increased Target to $44 on, Jan 8th, 2021

by: WOPRAI

Brock Vandervliet Upgraded (WAL) to Strong Buy and Increased Target to $83 on, Jan 8th, 2021

by: WOPRAI

James Lee Maintained (BABA) at Strong Buy with Decreased Target to $300 on, Jan 8th, 2021

by: WOPRAI

John Walsh Maintained (AYI) at Buy with Increased Target to $144 on, Jan 8th, 2021

by: WOPRAI

Chris Howerton Initiated (AXSM) at Strong Buy and Held Target at $129 on, Jan 8th, 2021

by: WOPRAI

Jayson Bedford Maintained (ANGO) at Strong Buy with Increased Target to $24 on, Jan 8th, 2021

by: WOPRAI

Jacob Hughes Downgraded (AMPH) to Hold and Held Target at $21 on, Jan 8th, 2021

by: WOPRAI

Thomas Gallagher Upgraded (UNM) to Hold and Increased Target to $25 on, Jan 8th, 2021

by: WOPRAI

Erin Wright Upgraded (TMO) to Buy and Increased Target to $556 on, Jan 8th, 2021

by: WOPRAI

Mike Dahl Downgraded (TMHC) to Hold and Decreased Target to $27 on, Jan 8th, 2021

by: WOPRAI

Ken Goldman Downgraded (THS) to Hold and Decreased Target to $46 on, Jan 8th, 2021

by: WOPRAI

Brian Tanquilut Upgraded (THC) to Strong Buy and Increased Target to $60 on, Jan 8th, 2021

by: WOPRAI

Mike Dahl Downgraded (TPH) to Hold and Decreased Target to $19 on, Jan 8th, 2021

by: WOPRAI

Pavel Molchanov Downgraded (TPIC) to Buy and Increased Target to $67 on, Jan 8th, 2021

by: WOPRAI

Pavel Molchanov Downgraded (XYL) to Hold on, Jan 8th, 2021

by: WOPRAI

Joseph Giordano Downgraded (XYL) to Sell and Held Target at $65 on, Jan 8th, 2021

by: WOPRAI

Jeff Cantwell Upgraded (WU) to Strong Buy on, Jan 8th, 2021

by: WOPRAI

Chris Terry Upgraded (X) to Strong Buy and Held Target at $28 on, Jan 8th, 2021

by: WOPRAI

Yaron Kinar Upgraded (BRO) to Strong Buy and Increased Target to $54 on, Jan 8th, 2021

by: WOPRAI

Brock Vandervliet Upgraded (BPOP) to Strong Buy and Increased Target to $79 on, Jan 8th, 2021

by: WOPRAI

Thomas Gallagher Upgraded (AFL) to Hold and Increased Target to $47 on, Jan 8th, 2021

by: WOPRAI

Anthony Vendetti Initiated (AEMD) at Strong Buy and Held Target at $60 on, Jan 8th, 2021

by: WOPRAI

Pavel Molchanov Maintained (AEIS) at Buy with Increased Target to $118 on, Jan 8th, 2021

by: WOPRAI

Rick Schafer Maintained (ADI) at Buy with Increased Target to $175 on, Jan 8th, 2021

by: WOPRAI

Yaron Kinar Upgraded (WRB) to Hold and Held Target at $31 on, Jan 8th, 2021

by: WOPRAI

Tim Savageaux Upgraded (AAOI) to Buy on, Jan 8th, 2021

by: WOPRAI

Sheila Kahyaoglu Maintained (AAL) at Sell with Increased Target to $12 on, Jan 8th, 2021

by: WOPRAI

Matthew O"Brien Maintained (ZBH) at Buy with Increased Target to $185 on, Jan 8th, 2021

by: WOPRAI

Melissa Franchi Maintained (ZS) at Hold with Increased Target to $180 on, Jan 8th, 2021

by: WOPRAI

Brian Bedell Maintained (TROW) at Hold with Increased Target to $163 on, Jan 8th, 2021

by: WOPRAI

Robert Dodd Maintained (TSLX) at Buy with Increased Target to $22 on, Jan 8th, 2021

by: WOPRAI

Chris McNally Upgraded (TSLA) to Hold and Held Target at $217 on, Jan 8th, 2021

by: WOPRAI

Arun Viswanathan Upgraded (CC) to Buy and Increased Target to $35 on, Jan 8th, 2021

by: WOPRAI

Jamie Rollo Maintained (CCL) at Sell with Increased Target to $14 on, Jan 8th, 2021

by: WOPRAI

Brock Vandervliet Downgraded (BKU) to Hold and Increased Target to $37 on, Jan 8th, 2021

by: WOPRAI

Geulah Livshits Initiated (CABA) at Strong Buy and Held Target at $21 on, Jan 8th, 2021

by: WOPRAI

Robert Moskow Maintained (CAG) at Sell with Decreased Target to $33 on, Jan 8th, 2021

by: WOPRAI

Steve Powers Maintained (CAG) at Hold with Decreased Target to $36 on, Jan 8th, 2021

by: WOPRAI

Juan Sanabria Downgraded (VTR) to Sell and Held Target at $49 on, Jan 8th, 2021

Chad Messer Maintained (SRPT) at Strong Buy with Decreased Target to $166 on, Jan 8th, 2021

Chad Messer of Needham, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Decreased Target from $182 to $166 on, Jan 8th, 2021.

Chad has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Chad's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chad

  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020

Like: 👍